Efficient gene delivery to vascular smooth muscle cells using a nontoxic, synthetic peptide vector system targeted to membrane integrins: a first step toward the gene therapy of chronic rejection.

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)589
Number of pages1
JournalTransplantation Proceedings
Volume33
Issue number1-2
Publication statusPublished - 2001

Cite this